SciSight Ecosystem
WoS SCIE Q3CAS 3区

Endocrine

Abbreviation (ISO):ENDOCRINE
Country: Updating•WoS SCIE Quartile: Q3•Identifier (ISSN):0969-711X(Print)•Articles / Year: 103
Clarivate IF (2026)Q3
3.3
↑ +0.4

Leading citation impact metric from Clarivate Journal Citation Reports

JCR Release Date: 2026-06-17
H-Index (Hirsch Index)
N/A

papers with at least that number of citations each

WoS: SCIE / JCRQ3
Self-Citation Rate6.7%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessSubscription
103articles/year
N/A Gold OA•N/A Original Research

State Council for Professorship (HĐGSNN) Scoring

Quyết định số 26/QĐ-HĐGSNN ngày 11/7/2025 (Mục quốc tế)

1.50pts
Latest Max Score
Estimated (Dec 26)
Scoring Basis: WoS Q3(IF: 3.3)

HĐGSNN Score History

By article publication year
YearMax ScoreEvaluation DetailsSource
20261.50đ
WoS Q3(IF: 3.3)
🔵 Computed
20251.50đ
WoS Q3(IF: 2.9)
🔵 Computed
20231.50đ
WoS Q3(IF: 3.7)
🔵 Computed
20221.50đ
WoS Q3(IF: 3.925)
🔵 Computed
20211.50đ
WoS Q3(IF: 3.633)
🔵 Computed
20201.50đ
WoS Q3(IF: 3.235)
🔵 Computed

Note: Domestic journal scores are officially collected from annual HĐGSNN decisions across councils. International journal scores are dynamically computed according to Decision 26/QĐ-HĐGSNN based on quartile and citation metrics in the publication year.

Aims & Scope

Well-established as a major journal in today’s rapidly advancing experimental and clinical research areas, Endocrine publishes original articles devoted to basic (including molecular, cellular and physiological studies), translational and clinical research in all the different fields of endocrinology and metabolism. Articles will be accepted based on peer-reviews, priority, and editorial decision. Invited reviews, mini-reviews and viewpoints on relevant pathophysiological and clinical topics, as well as Editorials on articles appearing in the Journal, are published. Unsolicited Editorials will be evaluated by the editorial team. Outcomes of scientific meetings, as well as guidelines and position statements, may be submitted. The Journal also considers special feature articles in the field of endocrine genetics and epigenetics, as well as articles devoted to novel methods and techniques in endocrinology. Endocrine covers controversial, clinical endocrine issues. Meta-analyses on endocrine and metabolic topics are also accepted. Descriptions of single clinical cases and/or small patients studies are not published unless of exceptional interest. However, reports of novel imaging studies and endocrine side effects in single patients may be considered. Research letters and letters to the editor related or unrelated to recently published articles can be submitted. Endocrine covers leading topics in endocrinology such as neuroendocrinology, pituitary and hypothalamic peptides, thyroid physiological and clinical aspects, bone and mineral metabolism and osteoporosis, obesity, lipid and energy metabolism and food intake control, insulin, Type 1 and Type 2 diabetes, hormones of male and female reproduction, adrenal diseases pediatric and geriatric endocrinology, endocrine hypertension and endocrine oncology.

Topics Covered (Recognized by AI)
Biology96.1%Medicine95.7%Internal medicine93.5%Endocrinology89.6%Chemistry88.9%Biochemistry86.9%Genetics82.5%Hormone52.7%Receptor39.8%Pathology32.9%Gene31.8%Psychology30.1%Cell biology27.6%Neuroscience23.9%Organic chemistry23.8%Physics22.3%Diabetes mellitus21.4%

SCImago & Scopus Journal Intelligence

Not indexed in SCImago / Scopus database

This journal is currently not indexed in Scopus or is an academic publication indexed exclusively in Web of Science (WoS).

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Medicine
Minor Category (Specific Field):
3区ENDOCRINOLOGY & METABOLISM
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Publisher Review Speed
Updating
Average time to first editorial decision
Online Publication Speed
Updating
Time from acceptance to online publication
Official Acceptance Rate
Updating
Manuscript acceptance rate confirmed by the publisher
Open Access Model
Subscription / Hybrid
OA publishing option or traditional subscription
Publisher
Updating
Publication Language
English
Frequency
Periodic
Indexing & Databases
SCIEScopus

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
CategoryIndexRankQuartile
ENDOCRINOLOGY & METABOLISM
JCRSCIE
100/198Q3
ENDOCRINOLOGY & METABOLISM
JCISCIE
108/198Q3

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

14 year
YearImpact FactorArticles / YearTotal Citations
20252.9——
20233.7——
20223.925——
20213.633——
20203.235——
2006—1034,208
2005—1216,618
2004—1053,518
2003—1183,946
2002—1134,617
2001—1384,021
2000—923,038
1999—632,149
1998—822,362
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Impact Factor Trend (2018–2024)

Clarivate IF trend for Endocrine

WoS Q3
2345202020212022202320252.90
Annual Impact Factor Metric
2025:2.9

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 6.7%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: f8da8650-9000-47af-a37f-a623e5fcee1a
Database Updated: 2026-10-01